PediaCare Shopper's Guide iPhone app released on the AppStore

PediaCare Shopper's Guide iPhone app released on the AppStore
PediaCare has launched the new PediaCare Shopper's Guide, a free iPhone application that will help parents of children ages 1-11 select the product which best addresses the cold symptoms their child is experiencing. It will also help parents to understand which products require a dosage recommendation from a pediatrician based on age restrictions and will provide a link to the PediaCare web site for full product descriptions including dosage directions.

The new PediaCare iPhone application, available in the iTunes store, coincides with the launch of PediaCare's new safe and effective cold/flu/fever medicines – with and without acetaminophen – for children and infants – in kid-pleasing flavors that match the formulations of the recent recall of children's Tylenol products. (PediaCare has eleven different products this cold/flu season helping fill the gap left when a popular brand of children's medicines were recalled this past year.)

While no app should replace the advice of a medical professional, this app and the many others geared toward parents are sure to help and save a lot of time!

PediaCare Shopper's Guide features:
+ Information that will help parents of children ages 1-11 to select which over-the-counter PediaCare product best addresses the symptoms their child is experiencing
+ Information to help parents understand which products require a dosage recommendation from a pediatrician based on age restrictions
+ Complete product information, including a link to the PediaCare web site for full product descriptions including dosage directions

PediaCare Shopper's Guide for iPhone is available for download FREE on the App Store in the Healthcare & Fitness category. The iPhone app is not a diagnostic tool, but is designed for informational purposes only and does not constitute a medical diagnosis.
Share :

0 comments on "PediaCare Shopper's Guide iPhone app released on the AppStore"

Post a Comment

Loading